G Biosciences
Private Company
Total funding raised: $5.2M
Overview
G-Biosciences is a privately held, revenue-generating provider of research reagents and custom manufacturing services, primarily targeting the proteomics and broader life sciences research markets. With over 25,000 citations for its products and ISO 13485:2016 certification, it has established credibility in research and diagnostic development support. The company's business model combines the sale of catalog products (like kits, buffers, and antibodies) with high-margin custom contract manufacturing and private-label services for other biotech firms. Its integrated approach as a one-stop shop for research tools and cGMP manufacturing presents a stable, though competitive, market position.
Technology Platform
Integrated portfolio of protein chemistry, purification, assay development, and cGMP manufacturing expertise for research reagents and diagnostic tools.
Funding History
11Opportunities
Risk Factors
Competitive Landscape
Operates in a crowded market dominated by giants like Thermo Fisher, Merck, and Bio-Rad. Competes by offering specialized, high-quality proteomics tools, a broad but integrated catalog, and value-added cGMP manufacturing services that larger players may not provide as flexibly. Faces additional competition from other specialized reagent vendors and CDMOs.